Emerging cell and gene therapies offer transformative outcomes for some of the world’s most challenging diseases. As these powerful and significant developments mature, it is increasingly important ...

The Biospecimen Management Consortium, a group that aims to develop industry standards and streamline operations in biospecimen lifecycle operations, has officially spun out of Richmond-based Slope as ...

Biospecimens from both healthy and diagnosed human subjects are key sources of information used throughout diagnostic and therapeutic development. Traditionally, these samples are sourced directly ...

SAN DIEGO, Sept. 16, 2025 /PRNewswire/ -- Sanguine Biosciences, a leading provider of healthy and disease-state human biospecimens and data for research, today announced the expansion of its oncology ...

Investigators who are writing grant applications and need a description of the Biospecimen Processing and Biorepository shared resource can find options below. Descriptions of the overall Fred ...

LEXINGTON, Mass., Dec. 16, 2021 /PRNewswire/ -- iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that it has expanded its ...

SAN DIEGO, Dec. 3, 2025 /PRNewswire/ -- Sanguine Biosciences, a leading provider of high-quality human biospecimens and real-world clinical data, today announced the expansion of its clinical sample ...

Richmond-based Slope on Tuesday announced it has rolled out new tech-enabled services to help pharmaceutical companies optimize operations and data involving biospecimens. Its new platform puts ...

iSpecimen, which provides an online marketplace platform for biospecimen procurement, filed on Thursday with the SEC to raise up to $21 million in an initial public offering. The company hopes to ...

MANASSAS, Va.--(BUSINESS WIRE)--ATCC, the world’s premier biological materials management and standards organization, today announced that it has been awarded a five-year contract with a ceiling value ...

The Administrative Core will provide for overall direction, coordination, and administration of the Case Gl SPORE, including oversight of the SPORE Executive Committee, SPORE Internal Advisory Board, ...

Patients age 18 years or older were eligible for enrollment at AUB. After consent, biospecimens were obtained at the time of routine diagnostic and/or therapeutic interventions. Both normal and ...